Kestra Medical Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KMTS and other ETFs, options, and stocks.

About KMTS

Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. It focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. 

CEO
Brian Webster
CEOBrian Webster
Employees
330
Employees330
Headquarters
Kirkland, Washington
HeadquartersKirkland, Washington
Founded
2014
Founded2014
Employees
330
Employees330

KMTS Key Statistics

Market cap
1.24B
Market cap1.24B
Price-Earnings ratio
-7.87
Price-Earnings ratio-7.87
Dividend yield
Dividend yield
Average volume
455.19K
Average volume455.19K
High today
$22.16
High today$22.16
Low today
$20.35
Low today$20.35
Open price
$21.14
Open price$21.14
Volume
85.24K
Volume85.24K
52 Week high
$30.00
52 Week high$30.00
52 Week low
$13.25
52 Week low$13.25

Stock Snapshot

With a market cap of 1.24B, Kestra Medical Technologies(KMTS) trades at $21.19. The stock has a price-to-earnings ratio of -7.87.

During the trading session on 2026-03-18, Kestra Medical Technologies(KMTS) shares reached a daily high of $22.16 and a low of $20.35. At a current price of $21.19, the stock is +4.1% higher than the low and still -4.4% under the high.

Trading volume for Kestra Medical Technologies(KMTS) stock has reached 85.24K, versus its average volume of 455.19K.

The stock's 52-week range extends from a low of $13.25 to a high of $30.00.

The stock's 52-week range extends from a low of $13.25 to a high of $30.00.

KMTS News

Seeking Alpha 15h
Kestra raises 2026 revenue guidance to $93M while advancing market expansion and margin gains

Earnings Call Insights Kestra raises 2026 revenue guidance to $93M while advancing market expansion and margin gains Mar. 17, 2026 7:13 PM ET Kestra Medical Tec...

Kestra raises 2026 revenue guidance to $93M while advancing market expansion and margin gains
The Motley Fool 16h
Kestra Medical Q3 2026 Earnings Transcript

Image source: The Motley Fool. Tuesday, March 17, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Brian Webster Chief Financial Officer — Vase...

Kestra Medical Q3 2026 Earnings Transcript
TipRanks 18h
Kestra Medical reports Q3 EPS (61c), consensus (60c)

Reports Q3 revenue $24.55M, consensus $22.87M. “Kestra delivered another strong quarter of financial performance, generating revenue growth of 63% while expandi...

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own KMTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.